Waltermire Robert E.
Insider CIK 1876996 · MDGL Senior VP, Chief Pharma Dev.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-03-05 | 2025-03-07 | 7,288 | — | $0 | 3,062 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2025-03-05 | 2025-03-07 | 1,157 | — | $0 | 1,157 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-03-05 | 2025-03-07 | 6,825 | — | $0 | 4,375 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-05 | 2025-03-07 | 1,043 | $341.84 | $356.5K | 10,918 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-05 | 2025-03-07 | 1,657 | $340.75 | $564.6K | 11,961 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-05 | 2025-03-07 | 400 | $339.68 | $135.9K | 13,618 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-05 | 2025-03-07 | 1,146 | $338.09 | $387.5K | 14,018 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-05 | 2025-03-07 | 1,777 | $336.78 | $598.5K | 15,164 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-05 | 2025-03-07 | 900 | $335.15 | $301.6K | 16,941 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-03-05 | 2025-03-07 | 7,288 | $87.09 | $634.7K | 17,841 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-03-05 | 2025-03-07 | 6,825 | $87.92 | $600.1K | 10,553 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-05 | 2025-03-07 | 1,412 | $344.76 | $486.8K | 3,728 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-05 | 2025-03-07 | 4,701 | $343.85 | $1.62M | 5,140 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-05 | 2025-03-07 | 1,077 | $342.90 | $369.3K | 9,841 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2025-03-05 | 2025-03-07 | 2,061 | — | $0 | 5,789 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-02-28 | 2025-03-04 | 175 | $341.55 | $59.8K | 3,728 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-02-28 | 2025-03-04 | 1,052 | $340.99 | $358.7K | 3,903 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-01-24 | 2025-01-27 | 103 | $335.24 | $34.5K | 4,955 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-01-17 | 2025-01-17 | 442 | $273.41 | $120.8K | 5,058 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-06-14 | 2024-06-18 | 1,900 | — | $0 | 10,350 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-06-14 | 2024-06-18 | 1,900 | $87.09 | $165.5K | 7,400 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-06-14 | 2024-06-18 | 1,900 | $280.00 | $532.0K | 5,500 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-06-12 | 2024-06-14 | 2,000 | — | $0 | 15,200 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-06-12 | 2024-06-14 | 2,000 | $87.92 | $175.8K | 7,500 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-06-12 | 2024-06-14 | 2,000 | $285.00 | $570.0K | 5,500 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-05-21 | 2024-05-23 | 1,036 | $231.34 | $239.7K | 5,500 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2024-01-23 | 2024-01-25 | 1,419 | — | $0 | 1,419 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2024-01-23 | 2024-01-25 | 2,138 | — | $0 | 2,138 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2024-01-23 | 2024-01-25 | 1,419 | — | $0 | 6,536 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | F Tax w/h | 2024-01-16 | 2024-01-18 | 550 | $243.92 | $134.2K | 5,117 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2023-12-15 | 2023-12-18 | 2,000 | — | $0 | 17,200 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-12-15 | 2023-12-18 | 1,000 | $236.00 | $236.0K | 6,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-12-15 | 2023-12-18 | 1,000 | $241.00 | $241.0K | 5,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2023-12-15 | 2023-12-18 | 2,000 | $87.92 | $175.8K | 7,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2023-12-14 | 2023-12-18 | 2,000 | — | $0 | 19,200 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2023-12-14 | 2023-12-18 | 2,000 | $87.92 | $175.8K | 7,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-12-14 | 2023-12-18 | 1,000 | $233.00 | $233.0K | 6,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-12-14 | 2023-12-18 | 1,000 | $232.00 | $232.0K | 5,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2023-12-13 | 2023-12-14 | 2,500 | — | $0 | 21,200 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-12-13 | 2023-12-14 | 1,000 | $226.00 | $226.0K | 5,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-12-13 | 2023-12-14 | 1,500 | $225.00 | $337.5K | 6,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2023-12-13 | 2023-12-14 | 2,500 | $87.92 | $219.8K | 8,167 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2023-12-12 | 2023-12-14 | 1,300 | — | $0 | 23,700 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-12-12 | 2023-12-14 | 800 | $219.00 | $175.2K | 5,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2023-12-12 | 2023-12-14 | 1,300 | $87.92 | $114.3K | 6,967 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-12-12 | 2023-12-14 | 500 | $216.00 | $108.0K | 6,467 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2023-03-01 | 2023-03-02 | 5,000 | — | $0 | 25,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2023-03-01 | 2023-03-02 | 5,000 | $87.92 | $439.6K | 10,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-03-01 | 2023-03-02 | 1,928 | $273.44 | $527.2K | 8,739 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-03-01 | 2023-03-02 | 1,672 | $274.57 | $459.1K | 7,067 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-03-01 | 2023-03-02 | 1,300 | $275.53 | $358.2K | 5,767 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-03-01 | 2023-03-02 | 100 | $276.19 | $27.6K | 5,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2023-02-28 | 2023-03-02 | 5,000 | — | $0 | 30,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-02-28 | 2023-03-02 | 900 | $271.03 | $243.9K | 9,767 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-02-28 | 2023-03-02 | 4,100 | $272.30 | $1.12M | 5,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2023-02-28 | 2023-03-02 | 5,000 | $87.92 | $439.6K | 10,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2023-01-16 | 2023-01-18 | 5,667 | — | $0 | 5,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2022-02-24 | 2022-02-24 | 12,250 | — | $0 | 12,250 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2021-08-02 | 2021-08-04 | 35,000 | — | $0 | 35,000 | SEC↗ |